https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2016-0514.html
This phase II trial studies how well brentuximab vedotin works in treating patients with CD30 positive (+) malignant mesothelioma that cannot be removed by...
phase ii trialbrentuximab vedotinadcetrismalignant
https://www.ajmc.com/view/over-6-years-first-line-brentuximab-vedotin-cuts-risk-of-death-in-hodgkin-lymphoma-by-41-
Data presented at ASCO show that after 6 years, patients with advanced Hodgkin lymphoma who were treated with a combination of brentuximab vedotin and...
first linebrentuximab vedotinyearscutsrisk